BioMedAI · Stage 3
Lab & Clinical
Validation
Drug safety, toxicity, PK/PD and clinical evidence, delivered through partner labs and collaborators. Use the results to improve your own integrated workflow.
Through partners
Stage 3
Completes the full AI Target Discovery → AI Drug Design → Lab & Clinical Validation pipeline
- Drug Safety
- Toxicity Assessment
- Pharmacokinetics / Pharmacodynamics (PK/PD)
- Clinical Evidence & Validation
AI Target Discovery — Live
AI Drug Design — In Dev
Lab & Clinical Validation — Through partners
Lab & Clinical Validation is Stage 3 — delivered through partner labs and collaborators.
Capabilities
What Lab & Clinical Validation Delivers
Drug Safety
Assess safety risks for your candidates early, so concerns surface before more time and money are invested.
Toxicity Assessment
Evaluate potential toxicity liabilities alongside efficacy and developability to prioritize safer candidates.
Pharmacokinetics / Pharmacodynamics (PK/PD)
Understand how a candidate is absorbed, distributed and cleared, and how exposure relates to its effect.
Clinical Evidence & Validation
Bring supporting evidence together to validate targets and candidates, delivered through partner labs and collaborators.
Early Access — Through Partners
Shape What We Build Next
Tell us about your validation needs — your input directly shapes which capability we build next.
Book a 30-min Discovery CallNo commitment. We're listening.
The Full BioMedAI Pipeline — AI Target Discovery Live, Lab & Clinical Validation Launching
From target discovery to clinical intelligence — explore the complete AI Target Discovery → AI Drug Design → Lab & Clinical Validation pipeline.